Home › Funds › Two Sigma Investments › REGN
Two Sigma Investments position in REGN
REGENERON PHARMACEUTICALS · Health Care
Latest position (Q2 2026)656.12K sh
Reported value held$409.12M
Portfolio Weight0.32%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 34.97K | $21.16M | New |
| Q4 2021 | 357.12K | $225.53M | Add |
| Q1 2022 | 207.43K | $144.87M | Reduce |
| Q4 2022 | 32.16K | $23.20M | New |
| Q1 2023 | 189.29K | $155.54M | Add |
| Q2 2023 | 123.63K | $88.83M | Reduce |
| Q3 2023 | 88.72K | $73.01M | Reduce |
| Q4 2023 | 65.22K | $57.28M | Reduce |
| Q1 2024 | 4.78K | $4.60M | Reduce |
| Q3 2024 | 22.39K | $23.54M | New |
| Q4 2024 | 34.54K | $24.61M | Add |
| Q1 2025 | 372.07K | $235.98M | Add |
| Q1 2025 | 372.07K | $235.98M | Add |
| Q2 2025 | 499.83K | $262.41M | Add |
| Q2 2025 | 499.83K | $262.41M | Add |
| Q3 2025 | 469.90K | $264.21M | Reduce |
| Q4 2025 | 281.15K | $217.01M | Reduce |
| Q1 2026 | 812.24K | $627.57M | Add |
| Q2 2026 | 656.12K | $409.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026
- AQR Capital Management 1.13M sh · $702.16M · Q2 2026